510 related articles for article (PubMed ID: 22526360)
21. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin.
Slavica L; Nurkkala-Karlsson M; Karlson T; Ingelsten M; Nyström J; Eriksson K
Scand J Immunol; 2012 Aug; 76(2):113-22. PubMed ID: 22519828
[TBL] [Abstract][Full Text] [Related]
22. Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
[TBL] [Abstract][Full Text] [Related]
23. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.
Ueno A; Cho S; Cheng L; Wang J; Hou S; Nakano H; Santamaria P; Yang Y
Diabetes; 2007 Jun; 56(6):1686-93. PubMed ID: 17360980
[TBL] [Abstract][Full Text] [Related]
24. (-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets.
Jeong YI; Jung ID; Lee JS; Lee CM; Lee JD; Park YM
Biochem Biophys Res Commun; 2007 Mar; 354(4):1004-9. PubMed ID: 17270146
[TBL] [Abstract][Full Text] [Related]
25. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
[TBL] [Abstract][Full Text] [Related]
26. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
[TBL] [Abstract][Full Text] [Related]
27. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
28. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
Hwang SL; Chung NP; Chan JK; Lin CL
Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
[TBL] [Abstract][Full Text] [Related]
29. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.
Jeong YI; Kim SW; Jung ID; Lee JS; Chang JH; Lee CM; Chun SH; Yoon MS; Kim GT; Ryu SW; Kim JS; Shin YK; Lee WS; Shin HK; Lee JD; Park YM
J Biol Chem; 2009 Feb; 284(6):3700-8. PubMed ID: 19075017
[TBL] [Abstract][Full Text] [Related]
30. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
31. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Lee JR; Jhaver KG; Johnson TS; Keskin DB; Marshall B; Chandler P; Antonia SJ; Burgess R; Slingluff CL; Mellor AL
Science; 2002 Sep; 297(5588):1867-70. PubMed ID: 12228717
[TBL] [Abstract][Full Text] [Related]
32. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
[TBL] [Abstract][Full Text] [Related]
33. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
[TBL] [Abstract][Full Text] [Related]
34. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
[TBL] [Abstract][Full Text] [Related]
35. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Habibi D; Jalili RB; Forouzandeh F; Ong CJ; Ghahary A
J Cell Physiol; 2010 Oct; 225(1):196-205. PubMed ID: 20648630
[TBL] [Abstract][Full Text] [Related]
36. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
37. Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli.
Von Bubnoff D; Scheler M; Wilms H; Fimmers R; Bieber T
J Immunol; 2011 Jun; 186(12):6701-9. PubMed ID: 21543643
[TBL] [Abstract][Full Text] [Related]
38. Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.
Furuzawa-Carballeda J; Lima G; Jakez-Ocampo J; Llorente L
Eur J Clin Invest; 2011 Oct; 41(10):1037-46. PubMed ID: 21366559
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]